ASH 2016 Annual Meeting Highlights in Hodgkin Lymphoma

Immunotherapy Stephen M. Ansell, MD, PhD Begin

Biomarkers Bruce D. Cheson, MD, FACP, FAAS Begin

PET-adapted Therapy Martin Hutchings, MD, PhD Begin

Anti-CD30 Therapy Alison J. Moskowitz, MD Begin